Additional Information

Description

Docetaxel 160 mg/16 mL is an intravenous chemotherapy agent used primarily in the treatment of various cancers, including breast, non-small cell lung cancer, prostate, and head and neck cancers. It is a synthetic taxane that works by inhibiting cancer cell division, ultimately leading to cell death. Docetaxel is an important therapeutic option due to its ability to interfere with the normal function of microtubules.

The mechanism of action of docetaxel involves its binding to tubulin, a protein that makes up the microtubules within the cell. By stabilizing microtubules and preventing their disassembly, docetaxel disrupts the normal process of mitosis, leading to arrest in the cell cycle. This prevents the proliferation of cancer cells, thereby reducing tumor growth.

Docetaxel is administered intravenously.It is typically given every 3 weeks, but specific treatment regimens may vary. The drug must be stored under controlled conditions, and patient monitoring for potential side effects is crucial.Common side effects of docetaxel include nausea, fatigue, low white blood cell count, and hair loss.